PAP immunoperoxidase method demonstrating endogenous estrogen in breast carcinomas.

Area of Science:

• Oncology
• Immunohistochemistry
• Biochemistry

Background:

• Estrogen receptor (ER) status is crucial for breast cancer prognosis and treatment.
• Traditional methods often require unphysiologic estrogen pretreatment.
• A need exists for methods that detect endogenous ER without exogenous hormone administration.

Purpose of the Study:

• To introduce and validate a novel PAP (peroxidase-anti-peroxidase) immunoperoxidase method for demonstrating estrogen receptors in breast carcinomas.
• To assess the method's ability to detect endogenous estrogen without pretreatment.
• To differentiate hormone-responsive from hormone-secreting cells.

Main Methods:

• Utilized a PAP immunoperoxidase technique on formalin-fixed, paraffin-embedded breast tumor specimens.
• Demonstrated endogenous estrogen receptor presence without exogenous estrogen pretreatment.
• Analyzed staining patterns (cytoplasmic and nuclear) to distinguish cell types.

Main Results:

• The PAP method successfully detected endogenous estrogen receptors in breast tumors.
• Endogenous estrogen was found in sufficient quantities in fixed tissues for detection.
• A high concordance (71.1% positive, 28.9% negative) was observed in 277 human breast carcinomas compared to biochemical assays.
• The method differentiated responsive (cytoplasmic and nuclear stain) from secreting (cytoplasmic stain only) cells.

Conclusions:

• The PAP immunoperoxidase method is a viable alternative for detecting estrogen receptors in breast cancer.
• This technique accurately identifies ER status without the need for unphysiologic hormone pretreatment.
• The method offers a valuable tool for distinguishing hormone-responsive and hormone-secreting cells in breast carcinomas.